BACKGROUND: The pathological processes in the first weeks of multiple sclerosis (MS) lesion formation include myelin digestion that breaks chemical bonds in myelin lipid layers. This can increase lesion magnetic susceptibility, which is a potentially useful biomarker in MS patient management, but not yet investigated. PURPOSE: To understand and quantify the effects of myelin digestion on quantitative susceptibility mapping (QSM) of MS lesions. STUDY TYPE: Histological and QSM analyses on in vitro models of myelin breakdown and MS lesion formation in vivo. POPULATION/SPECIMENS: Acutely demyelinating white matter lesions from MS autopsy tissue were stained with the lipid dye oil red O. Myelin basic protein (MBP), a major membrane protein of myelin, was digested with trypsin. Purified human myelin was denatured with sodium dodecyl sulfate (SDS). QSM was performed on phantoms containing digestion products and untreated controls. In vivo QSM was performed on five MS patients with newly enhancing lesions, and then repeated within 2 weeks. FIELD STRENGTH/SEQUENCE: 3D <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:mrow><mml:msubsup><mml:mi>T</mml:mi> <mml:mn>2</mml:mn> <mml:mo>*</mml:mo></mml:msubsup> </mml:mrow> </mml:math> -weighted spoiled multiecho gradient echo scans performed at 3T. ASSESSMENT: Region of interest analyses were performed by a biochemist and a neuroradiologist to determine susceptibility changes on in vitro and in vivo QSM images. STATISTICAL TESTS: Not applicable. RESULTS: MBP degradation by trypsin increased the QSM measurement by an average of 112 ± 37 ppb, in excellent agreement with a theoretical estimate of 111 ppb. Degradation of human myelin by SDS increased the QSM measurement by 23 ppb. As MS lesions changed from gadolinium enhancing to nonenhancing over an average of 15.8 ± 3.7 days, their susceptibility increased by an average of 7.5 ± 6.3 ppb. DATA CONCLUSION: Myelin digestion in the early stages of MS lesion formation contributes to an increase in tissue susceptibility, detectable by QSM, as a lesion evolves from gadolinium enhancing to nonenhancing. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2018;47:1281-1287.
BACKGROUND: The pathological processes in the first weeks of multiple sclerosis (MS) lesion formation include myelin digestion that breaks chemical bonds in myelin lipid layers. This can increase lesion magnetic susceptibility, which is a potentially useful biomarker in MSpatientmanagement, but not yet investigated. PURPOSE: To understand and quantify the effects of myelin digestion on quantitative susceptibility mapping (QSM) of MS lesions. STUDY TYPE: Histological and QSM analyses on in vitro models of myelin breakdown and MS lesion formation in vivo. POPULATION/SPECIMENS: Acutely demyelinating white matter lesions from MS autopsy tissue were stained with the lipid dye oil red O. Myelin basic protein (MBP), a major membrane protein of myelin, was digested with trypsin. Purified human myelin was denatured with sodium dodecyl sulfate (SDS). QSM was performed on phantoms containing digestion products and untreated controls. In vivo QSM was performed on five MSpatients with newly enhancing lesions, and then repeated within 2 weeks. FIELD STRENGTH/SEQUENCE: 3D <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:mrow><mml:msubsup><mml:mi>T</mml:mi> <mml:mn>2</mml:mn> <mml:mo>*</mml:mo></mml:msubsup> </mml:mrow> </mml:math> -weighted spoiled multiecho gradient echo scans performed at 3T. ASSESSMENT: Region of interest analyses were performed by a biochemist and a neuroradiologist to determine susceptibility changes on in vitro and in vivo QSM images. STATISTICAL TESTS: Not applicable. RESULTS:MBP degradation by trypsin increased the QSM measurement by an average of 112 ± 37 ppb, in excellent agreement with a theoretical estimate of 111 ppb. Degradation of human myelin by SDS increased the QSM measurement by 23 ppb. As MS lesions changed from gadolinium enhancing to nonenhancing over an average of 15.8 ± 3.7 days, their susceptibility increased by an average of 7.5 ± 6.3 ppb. DATA CONCLUSION: Myelin digestion in the early stages of MS lesion formation contributes to an increase in tissue susceptibility, detectable by QSM, as a lesion evolves from gadolinium enhancing to nonenhancing. LEVEL OF EVIDENCE: 1 Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2018;47:1281-1287.
Authors: Paul A Yushkevich; Joseph Piven; Heather Cody Hazlett; Rachel Gimpel Smith; Sean Ho; James C Gee; Guido Gerig Journal: Neuroimage Date: 2006-03-20 Impact factor: 6.556
Authors: Xu Li; Daniel M Harrison; Hongjun Liu; Craig K Jones; Jiwon Oh; Peter A Calabresi; Peter C M van Zijl Journal: J Magn Reson Imaging Date: 2015-06-14 Impact factor: 4.813
Authors: Cynthia Wisnieff; Sriram Ramanan; John Olesik; Susan Gauthier; Yi Wang; David Pitt Journal: Magn Reson Med Date: 2014-08-18 Impact factor: 4.668
Authors: Younjin Min; Kai Kristiansen; Joan M Boggs; Cynthia Husted; Joseph A Zasadzinski; Jacob Israelachvili Journal: Proc Natl Acad Sci U S A Date: 2009-02-13 Impact factor: 11.205
Authors: Vanessa Wiggermann; Enedino Hernández Torres; Irene M Vavasour; G R Wayne Moore; Cornelia Laule; Alex L MacKay; David K B Li; Anthony Traboulsee; Alexander Rauscher Journal: Neurology Date: 2013-06-12 Impact factor: 9.910
Authors: Weiwei Chen; Susan A Gauthier; Ajay Gupta; Joseph Comunale; Tian Liu; Shuai Wang; Mengchao Pei; David Pitt; Yi Wang Journal: Radiology Date: 2013-11-18 Impact factor: 11.105
Authors: S Zhang; T D Nguyen; S M Hurtado Rúa; U W Kaunzner; S Pandya; I Kovanlikaya; P Spincemaille; Y Wang; S A Gauthier Journal: AJNR Am J Neuroradiol Date: 2019-05-16 Impact factor: 3.825
Authors: C Elliott; D L Arnold; H Chen; C Ke; L Zhu; I Chang; E Cahir-McFarland; E Fisher; B Zhu; S Gheuens; M Scaramozza; V Beynon; N Franchimont; D P Bradley; S Belachew Journal: AJNR Am J Neuroradiol Date: 2020-08-20 Impact factor: 3.825
Authors: Cristina Granziera; Jens Wuerfel; Frederik Barkhof; Massimiliano Calabrese; Nicola De Stefano; Christian Enzinger; Nikos Evangelou; Massimo Filippi; Jeroen J G Geurts; Daniel S Reich; Maria A Rocca; Stefan Ropele; Àlex Rovira; Pascal Sati; Ahmed T Toosy; Hugo Vrenken; Claudia A M Gandini Wheeler-Kingshott; Ludwig Kappos Journal: Brain Date: 2021-06-22 Impact factor: 13.501
Authors: G Caruana; C Auger; L M Pessini; W Calderon; A de Barros; A Salerno; J Sastre-Garriga; X Montalban; À Rovira Journal: AJNR Am J Neuroradiol Date: 2022-03-24 Impact factor: 3.825
Authors: Colm Elliott; Jerry S Wolinsky; Stephen L Hauser; Ludwig Kappos; Frederik Barkhof; Corrado Bernasconi; Wei Wei; Shibeshih Belachew; Douglas L Arnold Journal: Mult Scler Date: 2018-12-19 Impact factor: 6.312
Authors: Christian Thaler; Anna A Kyselyova; Tobias D Faizy; Marie T Nawka; Sune Jespersen; Brian Hansen; Jan-Patrick Stellmann; Christoph Heesen; Klarissa H Stürner; Maria Stark; Jens Fiehler; Maxim Bester; Susanne Gellißen Journal: PLoS One Date: 2021-02-04 Impact factor: 3.240
Authors: Kelly M Gillen; Mayyan Mubarak; Calvin Park; Gerald Ponath; Shun Zhang; Alexey Dimov; Maya Levine-Ritterman; Steven Toro; Weiyuan Huang; Stephanie Amici; Ulrike W Kaunzner; Susan A Gauthier; Mireia Guerau-de-Arellano; Yi Wang; Thanh D Nguyen; David Pitt Journal: Ann Clin Transl Neurol Date: 2021-03-11 Impact factor: 4.511
Authors: Colm Elliott; Shibeshih Belachew; Jerry S Wolinsky; Stephen L Hauser; Ludwig Kappos; Frederik Barkhof; Corrado Bernasconi; Julian Fecker; Fabian Model; Wei Wei; Douglas L Arnold Journal: Brain Date: 2019-09-01 Impact factor: 13.501